The pathophysiology of irritable bowel syndrome and its treatment
Publication Date
August 4, 2021
Creator
Abstract
Irritable bowel syndrome (IBS) is a complex disorder of the gut causing abdominal pain, bloating and a change in bowel habit. Despite affecting approximately 10% of the general population, the exact causes are unknown and the treatments inadequate.
This thesis will start by introducing IBS and explore what is known currently about its pathology and treatment options. Chapters Two and Three will look at the role of different fibres in the gut using MRI. Chapter Two will describe the NOPAL study, assessing the effect of fibres of differing physico-chemical composition on intestinal physiology in healthy volunteers. Chapter Three describes the EFIGI study, assessing the effect of fibres alone and co-administered on intestinal physiology of patients with IBS.
The latter part of the thesis will look at the impact of ondansetron, a serotonin receptor-3 antagonist, as a treatment for diarrhoea-predominant IBS (IBS-D). Chapter Four will analyse a previous trial of ondansetron in patients with IBS-D to identify patients who benefit most from this treatment and further subclassify the disease. Chapter Five will describe the MOLID study which uses lactulose in healthy volunteers as a model for IBS-D, assessing the effect of ondansetron on the gut using MRI.
The thesis will conclude in Chapter Six discussing the studies described, and explore further research questions posed.
Item Type
ethesis
Thesis Type
PhD
Supervisors
Subjects (LC)
Associated Schools / Departments
School of Medicine
eprints ID
65594
UoN Repository URI
Except where otherwise noted, this item's license is described as
File(s)![Thumbnail Image]()
Name
Pathophysiology of IBS and its treatment - post viva amendments 030621.pdf
Type
Full-text
Description
Examined
Size
3.54 MB
Format
Adobe PDF
Checksum (MD5)
13653d69c1682afb1bca0be0d3dadd1e